Glenmark Pharmaceuticals (NSE:GLENMARK) Short Interest


NSE:GLENMARK Glenmark Pharmaceuticals Ltd NSE:GLENMARK
85 GF Score
Price ₹2,161.90
GF Value ₹1,985.75
Valuation Fairly Valued
View Full Analysis

What is Glenmark Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:GLENMARK vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Glenmark Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Glenmark Pharmaceuticals Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Glenmark Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Glenmark Pharmaceuticals's Short Interest falls into.


NSE:GLENMARK
85GF Score
Glenmark Pharmaceuticals Ltd NSE:GLENMARK
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Glenmark Pharmaceuticals (NSE:GLENMARK) Overvalued in 2026?

Based on GuruFocus' analysis, Glenmark Pharmaceuticals stock appears to be overvalued. The current stock price of ₹2,161.90 is trading 8.9% above its estimated GF Value™ of ₹1,985.75. GuruFocus considers Glenmark Pharmaceuticals to be Fairly Valued.

Key valuation signals for NSE:GLENMARK:

  • Short Interest:
  • GF Value™: ₹1,985.75 vs. price of ₹2,161.90 (8.9% above fair value)
  • GF Score™: 85/100

No single metric tells the full story. See the NSE:GLENMARK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Glenmark Pharmaceuticals Business Description

Other Exchanges 532296:India
Address B. D. Sawant Marg, Glenmark House, Chakala, Off Western Express Highway, Andheri (East), Mumbai, MH, IND, 400099
Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities. It has a business presence in different therapeutic areas such as dermatology, respiratory, oncology, diabetes, cardiovascular, and oral contraceptives among others. Geographically, it derives key revenue from India and the rest from North America, Latin America, Europe and the Rest of the world.
85GF Score

Get the complete analysis for NSE:GLENMARK

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,161.90
Price
₹1,985.75
GF Value